Allergic rhinitis in South Africa - diagnosis and management

South African Medical Journal

Volumn 86, Issue 10 II, 1996, Pages 1315-1328

  Luyt, David ^a   Green, Robin ^a   Alright, Patrick ^a   Bester, Charl ^a   Cohen, Desmond ^a   Crosland, Paul ^a   Davis, Gloria ^a   Davis, Martin ^a   Friedman, Raymond ^a   Hockman, Maurice ^a   Jooma, Farouk ^a   Lund, Valerie ^a   Manjra, Ahmed ^a   Mokgoadi, Fred ^a   Motala, Cas ^a   Nagel, Fred ^a   Ossip, Mervyn ^a   Potter, Paul ^a   Scott, Neil ^a   Steer, John ^a   Vermeulen, Jan ^a   Wolff, Lionel ^a   Weinberg, Eugene ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; IMMUNOGLOBULIN E; STEROID;

ALLERGIC RHINITIS; CLIMATE; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; EXTERNAL AUDITORY CANAL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; NOSE CONGESTION; PRICK TEST; PRURITUS; RADIOALLERGOSORBENT TEST; REVIEW; RHINOCONJUNCTIVITIS; RHINORRHEA; SEASONAL VARIATION; SLEEP DISORDER; SNEEZING; SOFT PALATE; SOUTH AFRICA; SYMPTOM;

DIAGNOSIS, DIFFERENTIAL; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SOUTH AFRICA;

EID: 0029827241     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Lund VJ, Aaronson D, Bousquet J, et al. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49: suppl 19.
2. Rutherford ML, Westfall RH. Biomes of Southern Africa: an objective characterization. In: Von Oudtshoorn F, ed. Guide to Grasses of South Africa (Memoirs of the Botanical Survey of South Africa, No. 54) Pretoria: Briza, 1992.
3. Von Mutius E, Fritzsch C, Weiland SK, Roll G, Magnussen H. Prevalence of asthma and allergic rhinitis among children in United Germany: a descriptive comparison. BMJ 1992; 305: 1395-1399.
4. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46: 895-901.
5. Wuthrich B, Schindler C, Levenberger P, Ackerman-Liebrich U. Prevalence of atopy and pollinosis in the adult population in Switzerland (SAPALDIA study). Swiss study on air pollution and lung diseases in adults. Int Arch Allergy Immunol 1995; 106: 149-156.
6. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaways MD. Atopy in childhood: gender and allergen related risks for the development of hayfever and asthma. Clin Exp Allergy 1993; 23: 941-948.
7. Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989; 19: 59-63.
8. Dotterud LK, Kvammen B, Bolle R, Falk ES. A survey of atopic diseases among school children in Sor-Varanger community: possible effects of subarctic climate and industrial pollution from Russia. Acta Derm Venereol (Stockh) 1994; 74: 124-128.
9. Charpin D, Hughes B, Mallea M, Sutra JP, Balansard G, Vervloet D. Seasonal allergic symptoms and their relation to pollen exposure in south-east France. Clin Exp Allergy 1993; 23: 435-439.
10. Ng TP, Tan WC. Epidemiology of chronic (perennial) rhinitis in Singapore: prevalence estimates, demographic variation and clinical allergic presentation. Ann Acad Med Singapore 1994; 23: 83-88.
11. Broder I, Higgins MW, Mathews KP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allergy Clin Immunol 1974; 53: 127-138.
12. Kaliner M. Allergic rhinitis. In: Mygind N, Naclerio RM, eds. Allergic and Non-Allergic Rhinitis: Clinical aspects. Copenhagen: Munksgaard. 1993: 153-158.
13. Berman D, Cooke R, Mullineux J, Potter P, Weinberg E. Pollen and Mould Allergens in Southern Africa. Cape Town: Citadel Press, 1983.
14. Luyt DK, Davis G. Skin prick tests - a measure of allergen exposure? Curr Allergy Clin Immunol 1994; 7: 4-7.
15. Potter PC, Mather S, Lockey P, Ainslie G, Cadman A. IgE specific immune responses to an African grass. Clin Exp Allergy 1993; 23: 581-586.
16. Potter PC, Berman D, Toerien A, Malherbe D, Weinberg EG. Clinical significance of aeroallergen identification in the Western Cape. S Afr Med J 1991; 79: 80-84.
17. Manjra A, Berman D, Weinberg EG, Gous E, Potter PC. Comparison between Acarex R test and Der-p-I ELISA for the detection of house-dust mites in the homes of asthma sufferers. S Afr Med J 1994; 84: 220-222.
18. Pipcorn U. Allergic rhinitis - diagnosis and treatment. In: Holgate ST, Church MK, eds. Allergy. London: Gower Medical Publishing, 1993; 18.1-18.10.
19. Potter PC, Buys C. Investigating the allergic patient. In: Potter PC, ed. The ALLSA Handbook of Practical Allergy. Cape Town: ALLSA, 1994: 1-16.
20. Weeke B, Poulsen L. Diagnostic tests for allergy. In: Holgate ST, Church MK, eds. Allergy. London: Gower Medical Publishing, 1993: 11.1-11.9.
21. Dreborg S. Skin tests for diagnosis of IgE mediated allergy. Allergy 1989; 44: suppl 10, 31-37.
22. White PJ, Potter PC, Malherbe D, Toerien A, Weinberg EG. A multi-allergen screening test for suspected allergic disease in coloured children. S Afr Med J 1989; 76: 597-598.
23. 23: Phelps PD. Radiology of the nose and paranasal sinuses. In: Scott-Brown's Diseases of the Ear, Nose and Throat. 5th ed. London: Butterworth Medical Publishing, 1987.
24. Van Duijn MP, Brouwer HJ. Use of signs and symptoms to diagnose maxillary sinusitis in general practice. BMJ 1992; 1: 179-182.
25. Mafee MF. Modern imaging of paranasal and the role of limited computerised sinus tomography; consideration of time, cost and radiation. Ear Nose Throat J 1994; 73: 530-546.
26. Ballantyne J, Groves J. The nose and sinuses. In: Scoff-Brown's Diseases of the Ear, Nose and Throat. 4th ed. London: Butterworth Medical Publishing, 1979: 209-224.
27. Simpson-Hall, Colman BH. Diseases of the Nose, Throat and Ear: A Handbook for Students and Practitioners. 13th ed. Edinburgh: Churchill Livingstone, 1987: 41-45.
28. Birrel JF. Paediatric Otolaryngology. Bristol: John Wright, 1978: 62-64.
29. Platts-Mills TAE. Reduction of bronchial reactivity during prolonged allergen avoidance. Lancet 1982; 2: 675-678.
30. Murray AB, Ferguson AC. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial. Pediatrics 1983; 71: 418-422.
31. Jooma OF, Weinberg EG, Berman D, Manjra Al, Potter PC. Accumulation of house-dust mite (Der-p-I) levels on matters covers. S Afr Med J 1995; 85: 1002-1005.
32. Korsgaard J. House dust mites and absolute indoor humidity. Allergy 1993; 38: 85-92.
33. Pauwels R. Mode of action of corticosteroids in asthma and rhinitis. Clin Allergy 1986; 16: 281-288.
34. Rak S, Jacobson MR, Sudderick RM, et al. Influence of prolonged treatment with topical corticosteroids (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994; 24: 930-939.
35. Naclerio RM, Creticos R, Norman PS, Hamilton R. Intranasal steroids suppress the seasonal rise in antigen specific IgE (Abstract). J Allergy Clin Immunol 1991; 87: 221.
36. Mygind N, Versterhauge S. Aerosol distribution in the nose. Rhinology 1978; 16: 78-88.
37. Agertoft L, Wolthers OD, Fuglsong G, Pedersen S. Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents. Pediatr Allergy Immunol 1993; 4: 152-156.
38. Damon Willems CF, Dinwiddie R, Grant DB, Rivers RPA, Zahir M, Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops. Eur J Pediatr 1994; 153: 632-634.
39. Bahtia M, Campbell LM, Ross JRM, Taylor MD, Peers EM, Richardson PDI. Intranasal budesonide once daily in seasonal allergic rhinitis. Curr Med Res Opin 1991; 12: 287-295.
40. Meltzer EO, Orgel HA, Bronshy EA, et al. A dose ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990; 86: 221-230.
41. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma; effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91: 97-100.
42. Bjerrum P, Illum P. Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate. Allergy 1985; 40: 65-69.
43. Bunnag C, Jareoncharsri P, Wong ECK. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy 1992; 47: 313-317.
44. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Ann Allergy 1994; 73: 497-502.
45. Mygind N. Glucocorticoids and rhinitis. Allergy 1993; 48: 476-490.
46. Sederberg-Warner ML. Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 1984; 105: 840-841.
47. Horak F, Bruttmann G, Pedrali P, Weeke B, Frolund L, Wolff HH, Christophers E. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Arzneidmittelforschung 1988; 38: 124-128.
48. Girard JP, Sommacal-Schopt D, Bigliardi P, Hanauer SA. Double-blind comparison of astemizole, terfenadine and placebo in hay fever with special regard to onset of action. J Int Med Res 1985; 13: 102-108.
49. Eda R, Sugiyama H, Hopp RJ, Bewtra AK, Townley RG. Effect of loratadine on human eosinophil in vitro. Ann Allergy 1993; 71: 373-378.
50. Kyan-Aung V, Hallsworth M, Haskard D, De Vos C. The effect of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells. J Allergy Clin Immunol 1993; 90: 270-272.
51. Jinquan T, Reimert CM, Deleuran B, Zachariae C, Simonsen C, Thestrup-Pedersen K. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T-lymphocytes and monocytes. J Allergy Clin Immunol 1995; 95(5) Part 1: 979-986.
52. Eda R, Townley RG, Hopp RJ. Effect of terfenadine on human eosinophil and neutrophil chemotactic responses and generation of superoxide. Ann Allergy 1994; 73: 154-160.
53. Richards DM, Brogden RN, Heel RC, Spreight TM, Avery GS. Astemizole: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1984; 28: 38-61.
54. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late phase reaction. J Allergy Clin Immunol 1989; 83: 905-912.
55. Hilbert J, Radwanski E, Weglein R, et al. Pharmacokinetics and dose proportionality of loratadine. J Clin Pharmacol 1987; 27: 694-698.
56. Sorkin EM, Heel RC. Terfenadine: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985; 29: 34-56.
57. Craft TM. Torsade de pointes after asternizole overdose. BMJ [Clin Res] 1986; 292: 660.
58. 1-antagonist in seasonal allergic rhinoconjunctivitis. Allergy 1987; 42: 512-515.
59. Davis R, Lund VJ, Harten-Ash VJ. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1993; 31: 159-164.
60. Mabry RL. Therapeutic agents in the medical management of sinusitis. Otolaryngol Clin North Am 1993; 26: 561-570.
61. Tami TA. Try a two-pronged therapy to clear the way for patients with sinusitis. Modern Med S Afr 1994; Feb: 21-30.
62. Krause HF. Pharmacologic therapy in otolaryngology patients. Surg Rounds 1993; June: 429-438.
63. Dushay M, Johnson C. Management of allergic rhinitis - focus on intranasal agents. Pharmacotherapy 1989; 9: 338-350.
64. Cos JSG. Disodium cromoglycate (FPL 670 "Intal"): a specific inhibitor of reagenic antigen - antibody mechanisms. Nature 1967; 216: 1328-1329.
65. King HC. Mast cell stabilizers. Otolaryngol Head Neck Surg 1992; 107: 841-844.
66. Vermeulen J, Mercer M. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Pediatr Allergy Immunol 1994; 5: 209-213.
67. Palma-Carlos AG, Chieira C, Conde TA, et al. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis. Ann Allergy 1991; 67: 394-398.
68. Schata M, Jorde W, Richarz-Barthauer U. Levocabastine nasal spray is better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1991; 87: 873-878.
69. Fisher WG. Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children. Ann Allergy 1994; 73: 515-520.
70. Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms - comparison of fluticasone proprionate and disodium cromoglycate nasal spray - a multicentre double blind, double dummy, parallel study. Allergy 1993; 48: 327-333.
71. Jackson RT, Teich-Graber J. Low dose topical atropine for rhinitis. Arch Otolaryngol 1981; 107: 288-289.
72. Weinberg EG. Allergic rhinitis. In: Potter PC, ed. The ALLSA Handbook of Practical Allergy. Cape Town: ALLSA, 1994: 17-24.
73. Krause HF. Therapeutic advances in the management of allergic rhinitis and urticaria. Otolaryngol Head Neck Surg 1994; 111: 364-372.
74. Mygind M. Progress in the drug management of allergic rhinitis. Eur Arch Otolaryngol Suppl 1995; 568-572.
75. Malling HJ. Immunotherapy position paper. Allergy 1993; 48 (14): suppl.
76. Malling HJ. The immunologic basis of immunotherapy. Curr Allergy 1992; 3: 30.
77. Weinberg EG. Allergen immunotherapy. In: Potter PC, ed. The ALLSA Handbook of Practical Allergy. Cape Town: ALLSA, 1994: 73-78.
78. Scadding GK, Alles R, Hawk L, Darby Y, Navas-Romero J, Martin JAM. Medical management of serous otitis media. Clin Exp Allergy 1993; 23: suppl, 14.
79. Nguyen CC. Chronic sinusitis among paediatric patients with chronic respiratory complaints. J Allergy Clin Immunol 1993; 6: 824-830.
80. McNicholas WT, Tarlo S, Cole P, et al. Obstructive sleep apnoea in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126: 625-628.
81. Lavie P, Gertner R, Zorner J, Podoslim L. Breathing disorders in sleep associated with microarousal in patients with allergic rhinitis. Acta Otolaryngol 1981; 92: 529-533.
82. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83.
83. Juniper EF, Guyatt GH, Anderson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993; 70: 225-230.
84. Bousquet J, Bullinger M, Fayol C, Morquis B, Valentin B, Burtin B. Assessment of quality of life of chronic allergic rhinitis using the SF-36 questionnaire. J Allergy Clin Immunol 1994; 94: 182-188.
85. Meltzer EO. Chronic rhinitis in children. Pediatr Clin North Am 1993; 30: 847-873.
86. Warner JO. Nasal allergy in children. In: Mackay IS, ed. Rhinitis: Mechanisms and management. London: Royal Society of Medicine Services, 1989: 215-224.
87. Renton R, Fidler C, Rosenberg R. Multicentre crossover study of the efficacy and tolerability of terfenadine 10 mg in perennial attergic rhinitis. Ann Allergy 1991; 67: 416-420.
88. Malm L, Änggård A. Vasoconstrictors. In: Mygind N, Naclerio RM, eds. Allergic and Non-Allergic Rhinitis: Clinical Aspects. Copenhagen: Munksgaard, 1993: 95-100.
89. Mabry RL. Rhinitis in pregnancy. South Med J 1986; 79: 965-971.
90. Welch AR, Birchall JP, Stafford FW. Occupational rhinitis - possible mechanisms of pathogenesis. J Laryngol Otol 1995; 109: 104-107.
91. Bernstein DI, Bernstein IL. Occupational asthma. In: Middleton JRE, ed. Allergy, Principles and Practice. Vol 2. 4th ed. St Louis: CV Mosby, 1993: 1369-1393.
92. Huther KJ, Renftle G, Barraud N, Burke JT, Koch-Weser J. Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol 1977; 12: 195-199.
93. 1-antagonist. Oxford: Medicine Publishing Foundation, 1984: 43-54.
94. Filderman RB, Rosen LJ. Comparison of onset and offset of inhibition of antigen-induced skin whealing of Seldane (terfenadine). Hismanal (astermizole) and placebo. J Allergy Clin Immunol 1987; 79: 190-198.
95. Package insert for Flixonase. Glaxo South Africa, 1991.